Survival analysis of time to develop cardiovascular complications and its predictors among hypertensive patients treated in the Ayder Comprehensive Specialized Hospital, Ethiopia: a retrospective cohort study (RCD code: VIII)

D. B. Tadesse, Gebre Yitayih, Weyzer Tilahun, Gebreamlak Gebremedhn, Kiros Belay, B. Hailu, Yohannes Ashebir, Gebre Teklemariam Demoz, Mulugeta Molla
{"title":"Survival analysis of time to develop cardiovascular complications and its predictors among hypertensive patients treated in the Ayder Comprehensive Specialized Hospital, Ethiopia: a retrospective cohort study (RCD code: VIII)","authors":"D. B. Tadesse, Gebre Yitayih, Weyzer Tilahun, Gebreamlak Gebremedhn, Kiros Belay, B. Hailu, Yohannes Ashebir, Gebre Teklemariam Demoz, Mulugeta Molla","doi":"10.20418/JRCD.VOL4NO3.386","DOIUrl":null,"url":null,"abstract":"Objective: Although hypertension is the leading cause of cardiovascular complications, time to develop cardiovascular complications among hypertensive patients has not been adequately investigated in Ethiopia. Therefore, the aim of this study was to assess time to develop cardiovascular complications and its predictors among adult hypertensive patients at the Ayder Comprehensive Specialized Hospital, Ethiopia. Result: A total of 578 hypertensive patients from the Cardiology Department were included in the study and followed for a total of 60 months (median 28 months). Half of the participants (290, 50.2%) were females. The median age of subjects was 54 years. Out of the 578 hypertensive patients who were analysed, 25.4% of them developed a cardiovascular complication. The incidence rate was 8.25 per 1000 persons per month. Significant predictors in the development of cardiovascular complications among hypertensive patients were age [AHR = 1.03 (95% CI=1.016, 1.046)], baseline cardiovascular complications [AHR=3.03 (95% CI=2.009, 4.870)], proteinuria [AHR=3.9 (95% CI=1.3, 11.68)], baseline systolic blood pressure [AHR =1.01 (95% CI=1.003, 2.012)], and baseline diastolic blood pres‐sure [AHR = 1.013 (95% CI=1.005, 2.021)]. JRCD 2019; 4 (4): 96-100.","PeriodicalId":37488,"journal":{"name":"Journal of Rare Cardiovascular Diseases","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rare Cardiovascular Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20418/JRCD.VOL4NO3.386","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: Although hypertension is the leading cause of cardiovascular complications, time to develop cardiovascular complications among hypertensive patients has not been adequately investigated in Ethiopia. Therefore, the aim of this study was to assess time to develop cardiovascular complications and its predictors among adult hypertensive patients at the Ayder Comprehensive Specialized Hospital, Ethiopia. Result: A total of 578 hypertensive patients from the Cardiology Department were included in the study and followed for a total of 60 months (median 28 months). Half of the participants (290, 50.2%) were females. The median age of subjects was 54 years. Out of the 578 hypertensive patients who were analysed, 25.4% of them developed a cardiovascular complication. The incidence rate was 8.25 per 1000 persons per month. Significant predictors in the development of cardiovascular complications among hypertensive patients were age [AHR = 1.03 (95% CI=1.016, 1.046)], baseline cardiovascular complications [AHR=3.03 (95% CI=2.009, 4.870)], proteinuria [AHR=3.9 (95% CI=1.3, 11.68)], baseline systolic blood pressure [AHR =1.01 (95% CI=1.003, 2.012)], and baseline diastolic blood pres‐sure [AHR = 1.013 (95% CI=1.005, 2.021)]. JRCD 2019; 4 (4): 96-100.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚Ayder综合专科医院高血压患者心血管并发症发生时间及其预测因素的生存分析:一项回顾性队列研究(RCD代码:VIII)
目的:虽然高血压是心血管并发症的主要原因,但在埃塞俄比亚尚未对高血压患者发生心血管并发症的时间进行充分调查。因此,本研究的目的是评估埃塞俄比亚Ayder综合专科医院成年高血压患者发生心血管并发症的时间及其预测因素。结果:来自心内科的578例高血压患者被纳入研究,共随访60个月(中位28个月)。一半的参与者(290人,50.2%)是女性。受试者的中位年龄为54岁。在578名被分析的高血压患者中,25.4%的人出现了心血管并发症。发病率为每月每1000人8.25例。高血压患者心血管并发症发生的重要预测因素有年龄[AHR= 1.03 (95% CI=1.016, 1.046)]、基线心血管并发症[AHR=3.03 (95% CI=2.009, 4.870)]、蛋白尿[AHR=3.9 (95% CI=1.3, 11.68)]、基线收缩压[AHR= 1.01 (95% CI=1.003, 2.012)]和基线舒张压[AHR= 1.013 (95% CI=1.005, 2.021)]。JRCD 2019;4(4): 96-100。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Rare Cardiovascular Diseases
Journal of Rare Cardiovascular Diseases Medicine-Cardiology and Cardiovascular Medicine
自引率
0.00%
发文量
0
审稿时长
23 weeks
期刊介绍: Journal of Rare Cardiovascular Diseases (JRCD) is an international, quarterly issued, peer-reviewed, open access, online journal that keeps cardiologists and non-cardiologists up-to-date with rare disorders of the heart and vessels. The Journal publishes fine quality review articles, original, basic and clinical sciences research papers, either positive or negative, case reports and articles on public health issues in the field of rare cardiovascular diseases and orphan cardiovascular drugs. Topics of interest include, but are not limited to the following areas: (1) rare diseases of systemic circulation (2) rare diseases of pulmonary circulation (3) rare diseases of the heart (cardiomyopathies) (4) rare congenital cardiovascular diseases (5) rare arrhythmogenic disorders (6) cardiac tumors and cardiovascular diseases in malignancy (7) cardiovascular diseases in pregnancy (8) basic science (9) quality of life
期刊最新文献
Association of fibrinogen and D‑dimer levels with severity of acute coronary syndromes Journal of Rare Cardiovascular Diseases in EuroPub database An Extremely Rare Congenital Association: Uni- cuspid Aortic Valve with Left Ventricular Noncom- paction (RCD code: III-5A.1.o) Survival analysis of time to develop cardiovascular complications and its predictors among hypertensive patients treated in the Ayder Comprehensive Specialized Hospital, Ethiopia: a retrospective cohort study (RCD code: VIII) Autoimmune hepatitis induced by bosentan in a patient with pulmonary arterial hypertension (RCD code: II‐1A.1; VIII)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1